Evolving developments in the management of COPD
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
PM Healthcare events are Quality Assured by the University of Bradford
| Satellite | Evolving developments in the management of COPD | |||
| Speakers | Professor Dave Singh, Professor of Clinical Pharmacology and Respiratory Medicine, University Hospital Of South Manchester NHS Foundation Trust Dave Singh is professor of clinical pharmacology & respiratory medicine at the University of Manchester. He graduated from Cambridge University and then trained in clinical pharmacology and respiratory medicine in Manchester, including postgraduate research. His research interest is the development of new drugs for asthma and COPD, involving clinical trials, biomarker studies and basic mechanisms. He has over 250 publications. He is a member of the GOLD Science Committee, and the chair of the ERS airway pharmacology group. He is the medical director of the Medicines Evaluation Unit, which performs both early and late phase clinical trials. | |||
| Satellite Description | ||||
|
COPD guideline update COPD Phenotypes Pharmacological treatment update
This sponsored session is organised and funded by Chiesi Ltd | ||||
| Sponsored By | Chiesi Ltd | |||
